6-K

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549

FORM6-K

Report of Foreign Private IssuerPursuant to Rule 13a-16 or 15d-16of the Securities Exchange Act of 1934

For the month of March 2023

Commission File No.: 001-35165

BRAINSWAY LTD.

(Translation of registrant's name into English)

19 Hartum StreetBynet Building, 3rd FloorHar HaHotzvimJerusalem, 9777518, Israel

(+972-2) 582-4030

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [ X ]      Form 40-F [   ]

CONTENTS

Results of Annual Shareholder Meeting

At the Annual General Meeting of Shareholders of BrainsWay Ltd. (the “Company”) held on March 20, 2023, all proposed resolutions were approved by the required majority of the shareholders. Below are the proposals which were adopted, as well as the respective share of support each resolution received:

(1) To appoint Kost Forer Gabbay & Kasierer, certified public accountants in Israel and a member of Ernst & Young Global, as the Company’s independent auditors for the year 2022 and for an additional period until the following annual general meeting and to authorize the Board of Directors to determine their compensation for the year; and to inform the shareholders of the aggregate compensation paid to the auditors for the year ended December 31, 2021.

(2) To approve the election or re-election of the following:

(a) Mr. Ami Boehm as a director on the Board of Directors of the Company until the next annual general meeting.

(b) Dr. David Zacut as a director on the Board of Directors of the Company until the next annual general meeting.

(c) Mr. Avner Hagai as a director on the Board of Directors of the Company until the next annual general meeting.

(d) Mr. Avner Lushi as a director on the Board of Directors of the Company until the next annual general meeting.

(e) Ms. Eti Mitrany as a director on the Board of Directors of the Company until the next annual general meeting.

(f) Ms. Karen Sarid as a director on the Board of Directors of the Company until the next annual general meeting.

(g) Prof. Avraham Zangen as a director on the Board of Directors of the Company until the next annual general meeting.

(h) Mr. Yossi Ben Shalom as a director on the Board of Directors of the Company until the next annual general meeting.

(3) To approve the compensation of Mr. Ami Boehm, in his capacity as Chairman of the Board of Directors, on the terms described in the Proxy Statement.

(4) To approve the compensation of Dr. David Zacut, for his role as a special consultant to the Company, on the terms described in the Proxy Statement.

(5) to approve the terms of compensation of Mr. Hadar Levy, the Company's Chief Executive Officer, on the terms described in the Proxy Statement.

(6) to approve an amendment of the Compensation Policy of the Company as set forth in the Proxy Statement.

Incorporation by Reference

The contents of this Form 6-K are incorporated by reference in the Company’s registration statement on Form F-3, on September 17, 2021 (Registration No. 333-259610), and Form S-8, SEC Registration No. 333-230979, filed by the Company with the SEC on April 22, 2019, and shall be a part thereof from the date on which this Form 6-K is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.